Standard BioTools Inc. Common Stock

LABNASDAQ • USD
0.62 USD
↘ 0.09 (12.10%)🟢LIVE (AS OF 01:59 PM EST)
🟢Market: OPEN

Shares of Standard BioTools Inc. Common Stock (LAB) are trading at $0.62. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (23.9%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.70
High?$0.72
Low?$0.62
Prev. Close?$0.71
Volume?344.6K
Avg. Volume?875.5K
VWAP?$0.65
Rel. Volume?0.39x
Bid / Ask
Bid?$0.53 × 100
Ask?$0.72 × 100
Spread?$0.19
Midpoint?$0.63
Valuation & Ratios
Market Cap?280.3M
Shares Out?394.8M
Float?222.8M
Float %?57.9%
P/E Ratio?2.11
P/B Ratio?0.50
EPS?$0.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Employees
389
Market Cap
279.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2011-02-10
Address
50 MILK STREET
BOSTON, MA 02109
Phone: (650) 266-6000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
3
Momentum?
55
Short Sent.?
83
Piotroski F-Score?6/9Mixed
Altman Z-Score?0.13Distress
Confidence?52%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?0.97%Low
Short Interest?2.2M
Days to Cover?3.1
Free Float222.8M
Avg Daily Volume706.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.75Strong
Quick Ratio?9.40Strong
Cash Ratio?5.24Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
93/100
P/E?
Peers
100
S&P
97
2.1CHEAP▾
P/B?
Peers
100
S&P
97
0.50CHEAP▾
P/S?
Peers
100
S&P
46
3.32FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.16CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
73
24.0%STRONG▾
ROA?
Peers
50
S&P
97
21.0%STRONG▾
Cash Flow & Enterprise
FCF?$-65649000
Enterprise Value?$13.1M
Fundamentals ratios updated end of day